Reddy MB - Search Results

1

Pharmacokinetic/Pharmacodynamic predictors of clinical potency for hepatitis C virus nonnucleoside polymerase and protease inhibitors.

Reddy MB, Morcos PN, Le Pogam S, Ou Y, Frank K, Lave T, Smith P. Reddy MB, et al. Antimicrob Agents Chemother. 2012 Jun;56(6):3144-56. doi: 10.1128/AAC.06283-11. Epub 2012 Apr 2. Antimicrob Agents Chemother. 2012. PMID: 22470110 Free PMC article.

2

Impact of low-dose ritonavir on danoprevir pharmacokinetics: results of computer-based simulations and a clinical drug-drug interaction study.

Reddy MB, Chen Y, Haznedar JO, Fretland J, Blotner S, Smith P, Tran JQ. Reddy MB, et al. Clin Pharmacokinet. 2012 Jul 1;51(7):457-65. doi: 10.2165/11599700-000000000-00000. Clin Pharmacokinet. 2012. PMID: 22624502 Clinical Trial.

3

Challenges and opportunities with modelling and simulation in drug discovery and drug development.

Lavé T, Parrott N, Grimm HP, Fleury A, Reddy M. Lavé T, et al. Xenobiotica. 2007 Oct-Nov;37(10-11):1295-310. doi: 10.1080/00498250701534885. Xenobiotica. 2007. PMID: 17968746

4

Physiological modeling and assessments of regional drug bioavailability of danoprevir to determine whether a controlled release formulation is feasible.

Reddy MB, Connor A, Brennan BJ, Morcos PN, Zhou A, McLawhon P, Fretland A, Evans P, Smith P, Tran JQ. Reddy MB, et al. Biopharm Drug Dispos. 2011 Jul;32(5):261-75. doi: 10.1002/bdd.756. Epub 2011 Jun 9. Biopharm Drug Dispos. 2011. PMID: 21660978 Clinical Trial.

5

The complete pharmacokinetic profile of serum cardiac troponin I in the rat and the dog.

Dunn ME, Coluccio D, Hirkaler G, Mikaelian I, Nicklaus R, Lipshultz SE, Doessegger L, Reddy M, Singer T, Geng W. Dunn ME, et al. Toxicol Sci. 2011 Oct;123(2):368-73. doi: 10.1093/toxsci/kfr190. Epub 2011 Jul 20. Toxicol Sci. 2011. PMID: 21775726

6

A Physiologically Based Pharmacokinetic Model for Ganciclovir and Its Prodrug Valganciclovir in Adults and Children.

Lukacova V, Goelzer P, Reddy M, Greig G, Reigner B, Parrott N. Lukacova V, et al. AAPS J. 2016 Nov;18(6):1453-1463. doi: 10.1208/s12248-016-9956-4. Epub 2016 Jul 22. AAPS J. 2016. PMID: 27450227

7

Physicochemical properties of the nucleoside prodrug R1626 leading to high oral bioavailability.

Brandl M, Wu X, Holper M, Hong L, Jia Z, Birudaraj R, Reddy M, Alfredson T, Tran T, Larrabee S, Hadig X, Sarma K, Washington C, Hill G, Smith DB. Brandl M, et al. Drug Dev Ind Pharm. 2008 Jul;34(7):683-91. doi: 10.1080/03639040701836636. Drug Dev Ind Pharm. 2008. PMID: 18612909

8

Differential analysis of transient increases of serum cTnI in response to handling in rats.

Mikaelian I, Dunn ME, Mould DR, Hirkaler G, Geng W, Coluccio D, Nicklaus R, Singer T, Reddy M. Mikaelian I, et al. Pharmacol Res Perspect. 2013 Dec;1(2):e00011. doi: 10.1002/prp2.11. Epub 2013 Dec 5. Pharmacol Res Perspect. 2013. PMID: 25505566 Free PMC article.

9

Physiologically Based Pharmacokinetic Modelling for First-In-Human Predictions: An Updated Model Building Strategy Illustrated with Challenging Industry Case Studies.

Miller NA, Reddy MB, Heikkinen AT, Lukacova V, Parrott N. Miller NA, et al. Among authors: reddy mb. Clin Pharmacokinet. 2019 Jun;58(6):727-746. doi: 10.1007/s40262-019-00741-9. Clin Pharmacokinet. 2019. PMID: 30729397 Review.

10

PBPK Modeling as a Tool for Predicting and Understanding Intestinal Metabolism of Uridine 5'-Diphospho-glucuronosyltransferase Substrates.

Reddy MB, Bolger MB, Fraczkiewicz G, Del Frari L, Luo L, Lukacova V, Mitra A, Macwan JS, Mullin JM, Parrott N, Heikkinen AT. Reddy MB, et al. Pharmaceutics. 2021 Aug 24;13(9):1325. doi: 10.3390/pharmaceutics13091325. Pharmaceutics. 2021. PMID: 34575401 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters